•  
  •  
  •  
  •  

2025-12-22 13:45:56

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Atishay Ltd awarded work order worth Rs. 1.67 crore
  • P N Gadgil Jewellers Ltd opens new store at Viman Nagar, Pune
  • Deccan Gold Mines Ltd begins pre-commissioning trials at Altyn Tor Gold Project
  • KIMS enters into agreement with Andhra Mahila Sabha to set up Super Speciality Hospital in Chennai
  • NHPC declares commercial operation of Unit 2 of Subansiri Lower HE project

Keywords Selected:  EugiaPharmaSpecialities

Stock Report

  • Aurobindo Pharma gets 9 observations from USFDA for Unit 2 of Eugia Pharma Specialities Ltd
  • Eugia Pharma receives USFDA Approval for Dasatinib Tablets
  • Eugia Pharma receives USFDA Approval for Pazopanib Tablets, 200 mg
  • Eugia Steriles Pvt Ltd receives EIR from USFDA for new injectable facility
  • Eugia Pharma Specialities Ltd receives 7 observations from USFDA for Unit II
  • Eugia Pharma Specialities Ltd restarts production at terminally sterilized product lines
  • Eugia Pharma Specialities Ltd receives USFDA final approval for Posaconazole Injection
  • Eugia Pharma receives USFDA Approval for Budesonide Inhalation Suspension, 0.5 mg/2 mL Single-Dose Ampule
  • Eugia Pharma receives USFDA Approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe
  • Eugia Pharma receives USFDA Approval for Vancomycin Hydrochloride for Injection USP, 1.25 g/vial and 1.5 g/vial, Single-Dose vials
  • US FDA completes inspection at Unit I of Eugia Pharma Specialities Ltd
  • Eugia Pharma receives USFDA Approval for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial
  • Eugia Pharma signs voluntary license with Medicines Patent Pool to develop and market generic version of Nilotinib Capsules
  • Eugia Pharma receives USFDA approval for Azacitidine for Injection
  • Eugia Pharma receives USFDA Approval for Amphotericin B Liposome for Injection
  • Eugia Pharma receives USFDA Approval for Triamcinolone Acetonide Injectable Suspension

Latest Post

  • Atishay Ltd awarded work order worth Rs. 1.67 crore
  • P N Gadgil Jewellers Ltd opens new store at Viman Nagar, Pune
  • Deccan Gold Mines Ltd begins pre-commissioning trials at Altyn Tor Gold Project
  • KIMS enters into agreement with Andhra Mahila Sabha to set up Super Speciality Hospital in Chennai
  • NHPC declares commercial operation of Unit 2 of Subansiri Lower HE project


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024